Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Appointed director
TransMedics Group, Inc. (TMDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 5,000 shares @ $54.22, valued at $271.1k
Exercised 5,000 options to buy @ $16.14, valued at $80.7k
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"TransMedics Completes Acquisition of Summit Aviation Andover, Mass. - August 16, 2023 - TransMedics Group, Inc. , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the closing of its previously announced acquisition of Summit Aviation, a premier U.S. charter flight operator. The acquisition enables the establishment of TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the U.S. “We are delighted to complete the acquisition of Summit Aviation, which represents a critical element of TransMedics' strategy to build and manage a national transplant logistics network designed to expand the reach and coverage of the Nat..."
08/04/2023 4 Ranganath Anil P. (See remarks) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 9,512 shares @ $0
Granted 14,709 options to buy @ $93.88, valued at $1.4M
08/04/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 4 Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 727 shares @ $91.91, valued at $66.8k
Sold 4,590 shares @ $92.9, valued at $426.4k
Sold 2,183 shares @ $93.77, valued at $204.7k
08/03/2023 8-K Quarterly results
Docs: "TransMedics Group, Inc.CONSOLIDATED STATEMENTS OF OPERATIONS"
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 4 Khayal Tamer I (Chief Commercial Officer) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 2,974 shares @ $90.05, valued at $267.8k
Sold 2,225 shares @ $90.02, valued at $200.3k
Exercised 2,974 options to buy @ $16.14, valued at $48k
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 2,257 shares @ $81.77, valued at $184.6k
Sold 4,653 shares @ $82.74, valued at $385k
Sold 590 shares @ $83.49, valued at $49.3k
06/29/2023 8-K Credit agreement amendment
Docs: "Second Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent",
"Second Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lenders party thereto and Canadian Imperial Bank of Commerce, as administrative agent"
06/07/2023 3 Ranganath Anil P. (See Remarks) has filed a Form 3 on TransMedics Group, Inc.
05/30/2023 4 KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 TOBIN JAMES R (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 RAINES MERILEE (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 Basile Edward M (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 Gunderson Thomas James (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 Weill David (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/30/2023 4 Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.
Txns: Granted 1,193 shares @ $0
Granted 1,916 options to buy @ $71.33, valued at $136.7k
05/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan"
05/11/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, by and between TransMedics Group, Inc. and U.S. Bank Trust Company, National Association (including the form of the 1.50% Convertible Senior Note due 2028)",
"Purchase Agreement, among TransMedics Group, Inc. and the several Initial Purchasers named in Schedule 1 thereto for whom Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC acted as Representatives",
"Form of Call Option Transaction Confirmation"
05/09/2023 8-K Credit agreement amendment
Docs: "First Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lender party thereto and Canadian Imperial Bank of Commerce, as administrative agent",
"First Amendment to Credit Agreement, by and among TransMedics Group, Inc., the lender party thereto and Canadian Imperial Bank of Commerce, as administrative agent"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 4 Gordon Stephen (CFO) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 5,000 shares @ $79.05, valued at $395.3k
Exercised 5,000 options to buy @ $16.14, valued at $80.7k
05/02/2023 4 Hassanein Waleed H (President & CEO) has filed a Form 4 on TransMedics Group, Inc.
Txns: Sold 5,406 shares @ $77.84, valued at $420.8k
Sold 1,759 shares @ $78.65, valued at $138.3k
Sold 335 shares @ $80.12, valued at $26.8k
05/01/2023 8-K Quarterly results
Docs: "TransMedics Group, Inc.CONSOLIDATED STATEMENTS OF OPERATIONS"
05/01/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy